Faculty ProfilesSindhu Chandran, MD
400 Parnassus Avenue
San Francisco, CA 94117
A transplant nephrologist with expertise in kidney and pancreas transplantation, Dr. Chandran earned her medical degree at All India Institute of Medical Sciences, and completed her residency at the University of Arizona. After completing her nephrology fellowship at Stanford University, she joined UCSF in 2010 for additional training in kidney transplantation and stayed on as a member of the transplant nephrology faculty. She is currently the Director of the Inpatient Kidney Transplant Unit.
Dr. Chandran is a member of the American Society of Nephrology and the American Society of Transplantation. She is board certified in internal medicine and nephrology. She has a strong background in renal physiology dating back to her research fellowship at Stanford during which she worked on the mechanisms of sodium transport in the distal nephron. At UCSF, she has focused her research interests on the treatment of renal graft inflammation with novel immunosuppressive regimens including cellular therapy with the overall goal of improving long term graft survival. Dr. Chandran is also involved in studying therapies that can promote tolerance in her role as an Associate Director with the clinical trials group at the Immune Tolerance Network.
Education and Training
|Location||Degree or Training||Specialty||Date|
|University of California, San Francisco||Clinical Fellowship||Transplant Nephrology||2011|
|Stanford University||Clinical & Research Fellowship||Nephrology||2010|
|University of Arizona||Internship & Residency||Medicine||2007|
|All India Institute of Medical Sciences||M.B., B.S.||School of Medicine||2002|
Related Web Sites
In the News
- HIV+ kidney failure patients face hurdles in receiving necessary transplants
- Prediabetes No Barrier to Kidney Donation
- Transplantation Issues: Kidney Donors and Children in Need of Transplants
- Exploring the Future of Prediabetic Living Kidney Donors
- Follow-Up of the Living Kidney Donor
- Study finds elevated preeclampsia risk after kidney donation
Recent Articles (27)
Wojciechowski D, Chandran S, Webber A, Hirose R, Vincenti F. Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients. Transplant Proc. 2017 Oct; 49(8):1773-1778.
Wojciechowski D, Chandran S, Yang JYC, Sarwal MM, Vincenti F. Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experience. Clin Transplant. 2017 Sep; 31(9).
Chandran S, Tang Q, Sarwal M, Laszik ZG, Putnam AL, Lee K, Leung J, Nguyen V, Sigdel T, Tavares EC, Yang JYC, Hellerstein M, Fitch M, Bluestone JA, Vincenti F. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants. Am J Transplant. 2017 Jul 04.
Abend JR, Changala M, Sathe A, Casey F, Kistler A, Chandran S, Howard A, Wojciechowski D. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients. Transplantation. 2017 Jun; 101(6):1495-1505.
Wojciechowski D, Chandran S, Vincenti F. Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients. Clin Transplant. 2017 May; 31(5).
Wu EH, Wojciechowski D, Chandran S, Yeh BM, Park M, Westphalen A, Wang ZJ. Prevalence of abdominal aortic calcifications in older living renal donors and its effect on graft function and histology. Transpl Int. 2015 Oct; 28(10):1172-8.
Wojciechowski D, Chandran S. Effect of ciprofloxacin combined with sulfamethoxazole-trimethoprim prophylaxis on the incidence of urinary tract infections after kidney transplantation. Transplantation. 2013 Aug 27; 96(4):400-5.
Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year. Transplantation. 2012 Dec 15; 94(11):1117-23.
Chandran S, Li H, Dong W, Krasinska K, Adams C, Alexandrova L, Chien A, Hallows KR, Bhalla V. Neural precursor cell-expressed developmentally down-regulated protein 4-2 (Nedd4-2) regulation by 14-3-3 protein binding at canonical serum and glucocorticoid kinase 1 (SGK1) phosphorylation sites. J Biol Chem. 2011 Oct 28; 286(43):37830-40.
Chandran S, Baxter-Lowe L, Olson JL, Tomlanovich SJ, Webber A. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report. Transplant Proc. 2011 Jun; 43(5):2097-101.
Hallows KR, Bhalla V, Oyster NM, Wijngaarden MA, Lee JK, Li H, Chandran S, Xia X, Huang Z, Chalkley RJ, Burlingame AL, Pearce D. Phosphopeptide screen uncovers novel phosphorylation sites of Nedd4-2 that potentiate its inhibition of the epithelial Na+ channel. J Biol Chem. 2010 Jul 09; 285(28):21671-8.